Abstract
In recent years, there has been a considerable amount of interest in the area of Genomic Signal Processing, which is the engineering discipline that studies the processing of genomic signals. Since regulatory decisions within the cell utilize numerous inputs, analytical tools are necessary to model the multivariate influences on decision-making produced by complex genetic networks. Signal processing approaches such as detection, prediction and classification have been used in the recent past to construct genetic regulatory networks capable of modeling genetic behavior. To accommodate the large amount of uncertainty associated with this kind of modeling, many of the networks proposed are probabilistic. One of the objectives of network modeling is to use the network to design different intervention approaches for affecting the time evolution of the gene activity profile of the network. More specifically, one is interested in intervening to help the network avoid undesirable states such as those associated with a disease. This paper provides a tutorial survey of the intervention approaches developed so far in the literature for probabilistic gene networks (probabilistic Boolean networks) and outlines some of the open challenges that remain.
Keywords: Gene regulatory network, markov chain, steady-state distribution, optimal control, dynamic programming, context sensitive networks
Current Bioinformatics
Title: Intervention in Probabilistic Gene Regulatory Networks
Volume: 1 Issue: 2
Author(s): Aniruddha Datta, Ranadip Pal and Edward R. Dougherty
Affiliation:
Keywords: Gene regulatory network, markov chain, steady-state distribution, optimal control, dynamic programming, context sensitive networks
Abstract: In recent years, there has been a considerable amount of interest in the area of Genomic Signal Processing, which is the engineering discipline that studies the processing of genomic signals. Since regulatory decisions within the cell utilize numerous inputs, analytical tools are necessary to model the multivariate influences on decision-making produced by complex genetic networks. Signal processing approaches such as detection, prediction and classification have been used in the recent past to construct genetic regulatory networks capable of modeling genetic behavior. To accommodate the large amount of uncertainty associated with this kind of modeling, many of the networks proposed are probabilistic. One of the objectives of network modeling is to use the network to design different intervention approaches for affecting the time evolution of the gene activity profile of the network. More specifically, one is interested in intervening to help the network avoid undesirable states such as those associated with a disease. This paper provides a tutorial survey of the intervention approaches developed so far in the literature for probabilistic gene networks (probabilistic Boolean networks) and outlines some of the open challenges that remain.
Export Options
About this article
Cite this article as:
Datta Aniruddha, Pal Ranadip and Dougherty R. Edward, Intervention in Probabilistic Gene Regulatory Networks, Current Bioinformatics 2006; 1 (2) . https://dx.doi.org/10.2174/157489306777011978
DOI https://dx.doi.org/10.2174/157489306777011978 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Attempted Cell Cycle Induction in Post-Mitotic Neurons Occurs in Early and Late Apoptotic Programs Through Rb, E2F1, and Caspase 3
Current Neurovascular Research Synthesis, DNA Binding Ability and Anticancer Activity of 2-heteroaryl Substituted Benzimidazoles Linked Pyrrolo[2,1-c][1,4]benzodiazepine Conjugates
Medicinal Chemistry Inhibition of Angiogenesis as a Treatment Strategy for Neuroblastoma
Current Cancer Therapy Reviews Curcumin Suppresses Tumor Growth and Angiogenesis in Human Glioma Cells Through Modulation of Vascular Endothelial Growth Factor/ Angiopoietin-2/Thrombospondin-1 Signaling
CNS & Neurological Disorders - Drug Targets Perspectives in Biomolecular Therapeutic Intervention in Cancer: From the Early to the New Strategies With Type I Interferons
Current Medicinal Chemistry Plant Defensins and Defensin-Like Peptides - Biological Activities and Biotechnological Applications
Current Pharmaceutical Design Recent Advances in Physical Approaches for Transdermal Penetration Enhancement
Current Drug Therapy Antitumor and Antiviral Activity of Pentacyclic Triterpenes
Mini-Reviews in Organic Chemistry Oligonucleotides and G-quadruplex Stabilizers: Targeting Telomeres and Telomerase in Cancer Therapy
Current Pharmaceutical Design Biomedical Applications of Gold Nanoparticles
Current Topics in Medicinal Chemistry Novel Inhibitors of Inosine Monophosphate Dehydrogenase in Patent Literature of the Last Decade
Recent Patents on Anti-Cancer Drug Discovery Biomarkers to Assess the Targeting of DNA Repair Pathways to Augment Tumor Response to Therapy
Current Molecular Medicine The Molecular Basis of Herpesviruses as Oncolytic Agents
Current Pharmaceutical Biotechnology Photodynamic Therapy: The Development of New Photosensitisers
Anti-Cancer Agents in Medicinal Chemistry Synthetic and Biological Vesicular Nano-Carriers Designed for Gene Delivery
Current Pharmaceutical Design Binding Sites of Amyloid β-Peptide in Cell Plasma Membrane and Implications for Alzheimers Disease
Current Protein & Peptide Science An Updated Organic Classification of Tyrosinase Inhibitors on Melanin Biosynthesis
Current Organic Chemistry Targeted Nanosystems to Prostate Cancer
Current Pharmaceutical Design Expression and Clinical Significance of Microtubule-Actin Cross-Linking Factor 1 in Serous Ovarian Cancer
Recent Patents on Anti-Cancer Drug Discovery Anti-Genes: siRNA, Ribozymes and Antisense
Current Pharmaceutical Biotechnology